Literature DB >> 11716568

Spontaneous paroxysmal circling behavior in the ci2 rat mutant: epilepsy with rotational seizures or hyperkinetic movement disorder?

S Lindemann1, A Lessenich, U Ebert, W Löscher.   

Abstract

Circling, turning, rotating, spinning, wheeling, and cursive hyperkinesia are all synonymous terms used to describe the active movement of an animal in a circular direction. Circling behavior can be evoked by unilateral electrical and chemical stimulation or lesions of various brain sites, but can also occur after systemic drug administration or spontaneously in normal animals or mutant rodents. In humans, stereotypic body rotation can occur as a distinctive entity of generalized and focal epilepsy, and may be due to involvement of the striatum. We have previously described a Lewis rat mutant (ci2) with a behavioral phenotype characterized by lateralized circling, hyperactivity, opisthotonus, and ataxia. In these rats, circling occurs in phases or bursts either spontaneously or in response to stress. Neurochemical data indicate that the circling behavior of the ci2 mutants is related to an abnormal asymmetry in dopaminergic activity in the striatum. Because of the similarities to rotational epilepsy, we used video and electroencephalographic recordings to study whether the rotational behavior of the ci2 mutant rat is a result of a partial or generalized epilepsy. Epileptic WAG/Rij rats were used for comparison. Video monitoring of ci2 rats in the absence of any stress or disturbance showed that circling occurs in paroxysmal bursts during active wakefulness, but not during passive wakefulness or sleep. Circling was not preceded or followed by any convulsive motor seizures and was not associated with epileptiform abnormalities in the electroencephalogram, whereas WAG/Rij rats exhibited myoclonic seizures and epileptic spike-wave discharges during passive wakefulness and sleep. As a result of the association of circling with active wakefulness, ci2 rats exhibited many more rotations during the dark (active) phase compared with the light (rest) period. Increase in active wakefulness during the light phase by transfer of the rats to a new environment induced or intensified circling behavior. Most ci2 rats showed a consistent lateral preference during circling, but some rats changed their preference from one session to another. The data indicate that spontaneous paroxysmal circling behavior in the ci2 rat is not a consequence of epilepsy but reflects a hyperkinetic movement disorder with abnormal lateralization of brain function. (c)2001 Elsevier Science.

Entities:  

Mesh:

Year:  2001        PMID: 11716568     DOI: 10.1006/exnr.2001.7802

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  4 in total

1.  The circling behavior of the deafblind LEW-ci2 rat is linked to a segment of RNO10 containing Myo15 and Kcnj12.

Authors:  Wojciech T Chwalisz; Bernd U Koelsch; Andrea Kindler-Röhrborn; Hans J Hedrich; Dirk Wedekind
Journal:  Mamm Genome       Date:  2003-09       Impact factor: 2.957

2.  Functional integration of new neurons into hippocampal networks and poststroke comorbidities following neonatal stroke in mice.

Authors:  S D Kadam; C L Smith-Hicks; D R Smith; P F Worley; A M Comi
Journal:  Epilepsy Behav       Date:  2010-06-17       Impact factor: 2.937

3.  Evidence for a Role of Orexin/Hypocretin System in Vestibular Lesion-Induced Locomotor Abnormalities in Rats.

Authors:  Leilei Pan; Ruirui Qi; Junqin Wang; Wei Zhou; Jiluo Liu; Yiling Cai
Journal:  Front Neurosci       Date:  2016-07-26       Impact factor: 4.677

4.  Brain Lateralization in Mice Is Associated with Zinc Signaling and Altered in Prenatal Zinc Deficient Mice That Display Features of Autism Spectrum Disorder.

Authors:  Stefanie Grabrucker; Jasmin C Haderspeck; Ann Katrin Sauer; Nadine Kittelberger; Harun Asoglu; Alireza Abaei; Volker Rasche; Michael Schön; Tobias M Boeckers; Andreas M Grabrucker
Journal:  Front Mol Neurosci       Date:  2018-01-15       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.